D-1041-2017 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1041-2017 was initiated by Zydus Pharmaceuticals USA Inc on May 10, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jan 7, 2020). Affected quantity: 108,096 HDPE bottles.

Recall details

Product Type
Drugs
Report Date
Aug 9, 2017
Initiation Date
May 10, 2017
Termination Date
Jan 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
108,096 HDPE bottles

Product description

Divalproex Sodium Delayed Release Tablets, USP, 125 mg, 100-count bottle Rx only, Manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ 07054, NDC 68382-031-01

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

MR6317 Exp.05/17 MR6318 Exp. 05/17 MR6319 Exp. 05/17 MR5361 Exp. 06/17 MR9007 Exp. 08/17 MR10000 Exp. 08/17 MR10923 Exp. 10/17 MR10924 Exp. 10/17 MR10925 Exp. 10/17 MR11554 Exp. 11/17 MR11555 Exp. 11/17 MS1359 Exp. 12/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1041-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1041-2017. Report a data issue: hello@regdatalab.com.